Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia
Abstract
There is now strong evidence that Neuregulin 1 (NRG1) is a susceptibility gene for schizophrenia. NRG1 mediates some of its effects through the tyrosine kinase receptor erbB4, and analysis of gene knock‐out animals suggests that the functional interaction of NRG1 and erbB4 mediates behaviors that may model some aspects of the schizophrenia phenotype in mice. Given these findings, we have sought evidence for association between schizophrenia and erbB4. Mutation screening of erbB4 in 14 DSMIV schizophrenics revealed 15 SNPs, none of which were nonsynonymous. Analysis of the allele frequencies of each SNP in pools of 368 DSMIV schizophrenics and 368 controls provided modest evidence for association with two of the SNPs, although individual genotyping in an extended sample of 680 cases did not confirm this. However, we did find evidence for a significant interaction between the NRG1 “Icelandic” schizophrenia risk haplotype and erbB4 (P = 0.019). The NRG1 and erbB4 interacting marker was further genotyped in an independent sample of 290 cases and 634 controls from Dublin. Interaction between NRG1 and erbB4 remained significant in the combined sample of 970 cases and 1,341 controls, OR = 2.98 (CI: 1.16–7.64), P = 0.01, although it only showed a trend in the Dublin sample alone (P = 0.11, two tailed). Our data require independent replication, but tentatively suggest that NRG1 may mediate its effects on schizophrenia susceptibility through functional interaction with erbB4, and that genetic interaction between variants at the two loci increases susceptibility to schizophrenia. © 2005 Wiley‐Liss, Inc.
Number of times cited: 104
- Dimitrios Avramopoulos, Neuregulin 3 and its roles in schizophrenia risk and presentation, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177, 2, (257-266), (2017).
- Martijn Selten, Hans van Bokhoven and Nael Nadif Kasri, Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders, F1000Research, 10.12688/f1000research.12155.1, 7, (23), (2018).
- Y.N. Dong, H. Lin, A. Rattelle, J. Panzer and D.R. Lynch, Excitotoxicity ☆, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.65836-1, (2017).
- Yanguo Feng, Dejun Cheng, Chaofeng Zhang, Yuchun Li, Zhiying Zhang, Juan Wang and Xiao Feng, Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia, Medicine, 10.1097/MD.0000000000005920, 96, 8, (e5920), (2017).
- Maria Auxiliadora Brasil Sampaio Cardoso, Tárcia Januário do Nascimento, Gabriel Pereira Bernardo, Lorena Pereira Bernardo, Maria Mirelle Ferreira Leite Barbosa, Pedro Januário Nascimento Neto, Danilo Ferreira de Sousa, Antonio Gilvan Teixeira Júnior, Marcos Antonio Pereira de Lima, Marcial Moreno Moreira, David de Sousa Gregório, Lídia Coelho do Nascimento Santos and Modesto Leite Rolim Neto, Are There Schizophrenia Genetic Markers and Mutations? A Systematic Review and Meta-Analyses, Health, 10.4236/health.2017.95058, 09, 05, (811-838), (2017).
- Larissa Erben, Ming-Xiao He, Annelies Laeremans, Emily Park and Andres Buonanno, A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution, Molecular Neurobiology, (2017).
- Xiangyou Hu, Qingyuan Fan, Hailong Hou and Riqiang Yan, Neurological dysfunctions associated with altered BACE1‐dependent Neuregulin‐1 signaling, Journal of Neurochemistry, 136, 2, (234-249), (2015).
- E. Von Cheong and Colm M.P. O’Tuathaigh, Modeling Gene–Gene Interactions in Schizophrenia, Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 10.1016/B978-0-12-800981-9.00019-5, (327-343), (2016).
- Brianna K. Unda, Vickie Kwan and Karun K. Singh, Neuregulin-1 Regulates Cortical Inhibitory Neuron Dendrite and Synapse Growth through DISC1, Neural Plasticity, 10.1155/2016/7694385, 2016, (1-15), (2016).
- Mohammadreza Mokhtari, Balaji Narayanan, Jordan P. Hamm, Pauline Soh, Vince D. Calhoun, Gualberto Ruaño, Mohan Kocherla, Andreas Windemuth, Brett A. Clementz, Carol A. Tamminga, John A. Sweeney, Matcheri S. Keshavan and Godfrey D. Pearlson, Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study, Schizophrenia Bulletin, 10.1093/schbul/sbv147, 42, 3, (851-862), (2015).
- Md Shaki Mostaid, David Lloyd, Benny Liberg, Suresh Sundram, Avril Pereira, Christos Pantelis, Tim Karl, Cynthia Shannon Weickert, Ian P. Everall and Chad A. Bousman, Neuregulin-1 and schizophrenia in the genome-wide association study era, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2016.06.001, 68, (387-409), (2016).
- Chenyao Wang, Branko Aleksic and Norio Ozaki, Glia‐related genes and their contribution to schizophrenia, Psychiatry and Clinical Neurosciences, 69, 8, (448-461), (2015).
- Michelle I. Mighdoll, Ran Tao, Joel E. Kleinman and Thomas M. Hyde, Myelin, myelin-related disorders, and psychosis, Schizophrenia Research, 10.1016/j.schres.2014.09.040, 161, 1, (85-93), (2015).
- Vanessa Douet, Linda Chang, Kristin Lee and Thomas Ernst, ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children, Brain Imaging and Behavior, 10.1007/s11682-015-9363-y, 9, 1, (128-140), (2015).
- Ann M. Hemmerle, Rebecca Ahlbrand, Stefanie L. Bronson, Kerstin H. Lundgren, Neil M. Richtand and Kim B. Seroogy, Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation, Schizophrenia Research, 10.1016/j.schres.2015.07.006, 168, 1-2, (411-420), (2015).
- Limin Wu, Samantha Walas, Wendy Leung, David B. Sykes, Jiang Wu, Eng H. Lo and Josephine Lok, Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells, Translational Stroke Research, 10.1007/s12975-014-0347-9, 6, 2, (116-124), (2014).
- D-M Yin, Y-J Chen, S Liu, H Jiao, C Shen, A Sathyamurthy, T W Lin, W-C Xiong, B-M Li, L Mei and C Bergson, Calcyon stimulates neuregulin 1 maturation and signaling, Molecular Psychiatry, 10.1038/mp.2014.131, 20, 10, (1251-1260), (2014).
- Sayomi Higa-Nakamine, Noriko Maeda, Seikichi Toku and Hideyuki Yamamoto, Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone, Journal of Biological Chemistry, 10.1074/jbc.M115.681700, 290, 43, (25974-25985), (2015).
- Judith Pratt and Paul J Harrison, Recent genetic findings in schizophrenia and their therapeutic relevance, Journal of Psychopharmacology, 10.1177/0269881114553647, 29, 2, (85-96), (2014).
- Sarah Tosato, Martina Zanoni, Chiara Bonetto, Federica Tozzi, Clyde Francks, Elisa Ira, Simona Tomassi, Mariaelena Bertani, Dan Rujescu, Ina Giegling, David St Clair, Michele Tansella, Mirella Ruggeri and Pierandrea Muglia, No Association Between NRG1 and ErbB4 Genes and Psychopathological Symptoms of Schizophrenia, NeuroMolecular Medicine, 10.1007/s12017-014-8323-9, 16, 4, (742-751), (2014).
- Anu Loukola, Jenni Hällfors, Tellervo Korhonen and Jaakko Kaprio, Genetics and Smoking, Current Addiction Reports, 10.1007/s40429-013-0006-3, 1, 1, (75-82), (2014).
- Li-Yeh Chuang, Hsien-Yuan Lane, Yu-Da Lin, Ming-Teng Lin, Cheng-Hong Yang and Hsueh-Wei Chang, Identification of SNP barcode biomarkers for genes associated with facial emotion perception using particle swarm optimization algorithm, Annals of General Psychiatry, 10.1186/1744-859X-13-15, 13, 1, (15), (2014).
- Catherine L. Winchester, Judith A. Pratt and Brian J. Morris, Risk genes for schizophrenia: Translational opportunities for drug discovery, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2014.02.003, 143, 1, (34-50), (2014).
- Lin Mei and Klaus-Armin Nave, Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases, Neuron, 10.1016/j.neuron.2014.06.007, 83, 1, (27-49), (2014).
- Xiongjian Luo, Liang Huang, Leng Han, Zhenwu Luo, Fang Hu, Roger Tieu and Lin Gan, Systematic Prioritization and Integrative Analysis of Copy Number Variations in Schizophrenia Reveal Key Schizophrenia Susceptibility Genes, Schizophrenia Bulletin, 10.1093/schbul/sbu045, 40, 6, (1285-1299), (2014).
- Cristi L. Galindo, Sergey Ryzhov and Douglas B. Sawyer, Neuregulin as a Heart Failure Therapy and Mediator of Reverse Remodeling, Current Heart Failure Reports, 10.1007/s11897-013-0176-2, 11, 1, (40-49), (2013).
- A Loukola, J Wedenoja, K Keskitalo-Vuokko, U Broms, T Korhonen, S Ripatti, A-P Sarin, J Pitkäniemi, L He, A Häppölä, K Heikkilä, Y-L Chou, M L Pergadia, A C Heath, G W Montgomery, N G Martin, P A F Madden and J Kaprio, Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample, Molecular Psychiatry, 10.1038/mp.2013.72, 19, 5, (615-624), (2013).
- Dipesh Joshi, Janice M. Fullerton and Cynthia Shannon Weickert, Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia, Journal of Psychiatric Research, 10.1016/j.jpsychires.2014.02.014, 53, (125-132), (2014).
- Dairong Feng and Jiuyong Xie, Aberrant splicing in neurological diseases, Wiley Interdisciplinary Reviews: RNA, 4, 6, (631-649), (2013).
- A Hatzimanolis, J A McGrath, R Wang, T Li, P C Wong, G Nestadt, P S Wolyniec, D Valle, A E Pulver and D Avramopoulos, Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients, Translational Psychiatry, 10.1038/tp.2013.33, 3, 5, (e264), (2013).
- Emma Sprooten, Kathryn M. Fleming, Pippa A. Thomson, Mark E. Bastin, Heather C. Whalley, Jeremy Hall, Jess E. Sussmann, James McKirdy, Douglas Blackwood, Stephen M. Lawrie and Andrew M. McIntosh, White matter integrity as an intermediate phenotype: Exploratory genome-wide association analysis in individuals at high risk of bipolar disorder, Psychiatry Research, 10.1016/j.psychres.2012.11.002, 206, 2-3, (223-231), (2013).
- Javier Gilabert-Juan, Maria Belles, Ana Rosa Saez, Hector Carceller, Sara Zamarbide-Fores, Maria Dolores Moltó and Juan Nacher, A “double hit” murine model for schizophrenia shows alterations in the structure and neurochemistry of the medial prefrontal cortex and the hippocampus, Neurobiology of Disease, 10.1016/j.nbd.2013.07.008, 59, (126-140), (2013).
- Nicholas C. Stefanis, Alex Hatzimanolis, Nikolaos Smyrnis, Dimitrios Avramopoulos, Ioannis Evdokimidis, Jim van Os, Costas N. Stefanis, Richard E. Straub and Daniel R. Weinberger, Schizophrenia Candidate Gene ERBB4: Covert Routes of Vulnerability to Psychosis Detected at the Population Level, Schizophrenia Bulletin, 10.1093/schbul/sbr169, 39, 2, (349-357), (2011).
- J Lagopoulos, D F Hermens, S N Hatton, R A Battisti, J Tobias-Webb, D White, S L Naismith, E M Scott, W J Ryder, M R Bennett and I B Hickie, Microstructural white matter changes are correlated with the stage of psychiatric illness, Translational Psychiatry, 10.1038/tp.2013.25, 3, 4, (e248), (2013).
- Fernando de Castro, Ana Bribián and Mª Cristina Ortega, Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology, Cellular and Molecular Life Sciences, 10.1007/s00018-013-1365-6, 70, 22, (4355-4368), (2013).
- Melis Inan, Timothy J. Petros and Stewart A. Anderson, Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia, Neurobiology of Disease, 10.1016/j.nbd.2012.11.013, 53, (36-48), (2013).
- Nagahide Takahashi and Takeshi Sakurai, Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches, Neurobiology of Disease, 10.1016/j.nbd.2012.11.001, 53, (49-60), (2013).
- Isabel del Pino, Cristina García-Frigola, Nathalie Dehorter, Jorge R. Brotons-Mas, Efrén Alvarez-Salvado, María Martínez de Lagrán, Gabriele Ciceri, María Victoria Gabaldón, David Moratal, Mara Dierssen, Santiago Canals, Oscar Marín and Beatriz Rico, Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes, Neuron, 10.1016/j.neuron.2013.07.010, 79, 6, (1152-1168), (2013).
- Joon Seol Bae, Charisse Flerida A. Pasaje, Byung-Lae Park, Hyun Sub Cheong, Jeong-Hyun Kim, Jason Yongha Kim, Joong-Gon Shin, Chul Soo Park, Bong-Jo Kim, Cheol-Soon Lee, Migyung Lee, Woo Hyuk Choi, Tae-Min Shin, Jaewook Hwang, Hyoung Doo Shin and Sung-Il Woo, Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population, Brain Research, 10.1016/j.brainres.2012.05.029, 1466, (146-151), (2012).
- C S Weickert, Y Tiwari, P R Schofield, B J Mowry and J M Fullerton, Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity, Translational Psychiatry, 10.1038/tp.2012.25, 2, 4, (e104), (2012).
- Yun Du, Huaiyu Yang, Yechun Xu, Xiaohui Cang, Cheng Luo, Yanyan Mao, Yuanyuan Wang, Guangrong Qin, Xiaomin Luo and Hualiang Jiang, Conformational Transition and Energy Landscape of ErbB4 Activated by Neuregulin1β: One Microsecond Molecular Dynamics Simulations, Journal of the American Chemical Society, 10.1021/ja211941d, 134, 15, (6720-6731), (2012).
- Beatriz Rico, Finding a druggable target for schizophrenia: Fig. 1., Proceedings of the National Academy of Sciences, 10.1073/pnas.1209389109, 109, 30, (11902-11903), (2012).
- Peng Chen, Jianhua Chen, Ke Huang, Weidong Ji, Ti Wang, Tao Li, Yang Wang, Hankun Wang, Lin He, Guoyin Feng and Yongyong Shi, Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2011.09.011, 36, 1, (17-21), (2012).
- James T. R. Walters, Michael O'Donovan and Michael J. Owen, The Genetics of Schizophrenia, Schizophrenia, (109-140), (2011).
- Brien Riley and Kenneth S. Kendler, Classical Genetic Studies of Schizophrenia, Schizophrenia, (245-268), (2011).
- Nagahide Takahashi, Takeshi Sakurai, Kenneth L. Davis and Joseph D. Buxbaum, Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia, Progress in Neurobiology, 10.1016/j.pneurobio.2010.09.004, 93, 1, (13-24), (2011).
- Amy E. Geddes, Xu-Feng Huang and Kelly A. Newell, Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2011.02.017, 35, 4, (896-904), (2011).
- Riccardo Zuliani, T. William J. Moorhead, Mark E. Bastin, Eve C. Johnstone, Stephen M. Lawrie, Paolo Brambilla, Michael C. O'Donovan, Michael J. Owen, Jeremy Hall and Andrew M. McIntosh, Genetic variants in the ErbB4 gene are associated with white matter integrity, Psychiatry Research: Neuroimaging, 10.1016/j.pscychresns.2010.11.001, 191, 2, (133-137), (2011).
- N Takahashi, T Sakurai, O Bozdagi-Gunal, N P Dorr, J Moy, L Krug, M Gama-Sosa, G A Elder, R J Koch, R H Walker, P R Hof, K L Davis and J D Buxbaum, Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes, Translational Psychiatry, 10.1038/tp.2011.8, 1, 5, (e8), (2011).
- Beatriz Rico and Oscar Marín, Neuregulin signaling, cortical circuitry development and schizophrenia, Current Opinion in Genetics & Development, 10.1016/j.gde.2010.12.010, 21, 3, (262-270), (2011).
- Graham M Pitcher, Lorraine V Kalia, David Ng, Nathalie M Goodfellow, Kathleen T Yee, Evelyn K Lambe and Michael W Salter, Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors, Nature Medicine, 10.1038/nm.2315, 17, 4, (470-478), (2011).
- Hon‐Cheong So, Pui Y. Fong, Ronald Y.L. Chen, Tomy C.K. Hui, Mandy Y.M. Ng, Stacey S. Cherny, William W.M. Mak, Eric F.C. Cheung, Raymond C.K. Chan, Eric Y.H. Chen, Tao Li and Pak C. Sham, Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 1, (103-113), (2009).
- Victor Z. Chong, Mia Thompson, Senda Beltaifa, Maree J. Webster, Amanda J. Law and Cynthia Shannon Weickert, Aumento de los valores de las proteínas neurregulina 1 y ErbB4 en la corteza prefrontal de pacientes esquizofrénicos, Psiquiatría Biológica, 10.1016/j.psiq.2010.04.002, 17, 2, (54-62), (2010).
- Ina Giegling, Just Genius, Jens Benninghoff and Dan Rujescu, Genetic findings in schizophrenia patients related to alterations in the intracellular Ca-homeostasis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2010.06.018, 34, 8, (1375-1380), (2010).
- Yu Feng, Xiao-Dong Wang, Chun-Mei Guo, Yang Yang, Ji-Tao Li, Yun-Ai Su and Tian-Mei Si, Expressions of Neuregulin 1 and ErbB4 in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by Chronic MK-801 Administration , Journal of Biomedicine and Biotechnology, 10.1155/2010/859516, 2010, (1-7), (2010).
- Jörg Neddens and Andrés Buonanno, Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice, Hippocampus, 20, 6, (724-744), (2009).
- Anamika Banerjee, Mathew L. MacDonald, Karin E. Borgmann-Winter and Chang-Gyu Hahn, Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome, Brain Research Bulletin, 10.1016/j.brainresbull.2010.04.011, 83, 3-4, (132-139), (2010).
- Andrés Buonanno, The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits, Brain Research Bulletin, 10.1016/j.brainresbull.2010.07.012, 83, 3-4, (122-131), (2010).
- Stefano Marenco and Eugenia Radulescu, Imaging genetics of structural brain connectivity and neural integrity markers, NeuroImage, 10.1016/j.neuroimage.2009.11.030, 53, 3, (848-856), (2010).
- Chao-Lin Lu, Ying-Chieh Wang, Jen-Yeu Chen, I-Ching Lai and Ying-Jay Liou, Support for the involvement of the ERBB4 gene in schizophrenia: A genetic association analysis, Neuroscience Letters, 10.1016/j.neulet.2010.06.067, 481, 2, (120-125), (2010).
- L. Wen, Y.-S. Lu, X.-H. Zhu, X.-M. Li, R.-S. Woo, Y.-J. Chen, D.-M. Yin, C. Lai, A. V. Terry, A. Vazdarjanova, W.-C. Xiong and L. Mei, Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons, Proceedings of the National Academy of Sciences, 10.1073/pnas.0910302107, 107, 3, (1211-1216), (2009).
- Randal G. Ross, Karen E. Stevens, William R. Proctor, Sherry Leonard, Michael A. Kisley, Sharon K. Hunter, Robert Freedman and Catherine E. Adams, Research Review: Cholinergic mechanisms, early brain development, and risk for schizophrenia, Journal of Child Psychology and Psychiatry, 51, 5, (535-549), (2009).
- Jonathan D. Wood, Franziska Bonath, Shashvita Kumar, Christopher A. Ross and Vincent T. Cunliffe, Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain, Human Molecular Genetics, 10.1093/hmg/ddn361, 18, 3, (391-404), (2008).
- Sibylle G Schwab and Dieter B Wildenauer, Update on key previously proposed candidate genes for schizophrenia, Current Opinion in Psychiatry, 10.1097/YCO.0b013e328325a598, 22, 2, (147-153), (2009).
- Pat Levitt and Daniel B. Campbell, The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders, Journal of Clinical Investigation, 10.1172/JCI37934, 119, 4, (747-754), (2009).
- Sheryl S. Moy, H. Troy Ghashghaei, Randal J. Nonneman, Jill M. Weimer, Yukako Yokota, Daekee Lee, Cary Lai, David W. Threadgill and E. S. Anton, Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia, Journal of Neurodevelopmental Disorders, 10.1007/s11689-009-9017-8, 1, 4, (302-312), (2009).
- Hans O. Kalkman, Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.11.002, 121, 1, (115-122), (2009).
- J.W. Dickerson, A.M. Hemmerle, S. Numan, K.H. Lundgren and K.B. Seroogy, Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats, Neuroscience, 10.1016/j.neuroscience.2009.06.008, 163, 1, (482-489), (2009).
- Andreas Konrad, Goran Vucurevic, Francesco Musso, Peter Stoeter, Norbert Dahmen and Georg Winterer, ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain, Neuropsychopharmacology, 10.1038/npp.2008.112, 34, 3, (641-650), (2008).
- Jeremy Hall, Liana Romaniuk, Andrew M. McIntosh, J. Douglas Steele, Eve C. Johnstone and Stephen M. Lawrie, Associative learning and the genetics of schizophrenia, Trends in Neurosciences, 10.1016/j.tins.2009.01.011, 32, 6, (359-365), (2009).
- Myriam Cayre, Peter Canoll and James E. Goldman, Cell migration in the normal and pathological postnatal mammalian brain, Progress in Neurobiology, 10.1016/j.pneurobio.2009.02.001, 88, 1, (41-63), (2009).
- André Fisahn, Jörg Neddens, Leqin Yan and Andrés Buonanno, Neuregulin-1 Modulates Hippocampal Gamma Oscillations: Implications for Schizophrenia, Cerebral Cortex, 10.1093/cercor/bhn107, 19, 3, (612-618), (2008).
- Yoshihito Ito, Shinnosuke Yamada, Nagahide Takahashi, Shinichi Saito, Akira Yoshimi, Toshiya Inada, Yukihiro Noda and Norio Ozaki, No association between the protein tyrosine phosphatase, receptor‐type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 7, (1013-1018), (2008).
- Graham M. Pitcher, Simon Beggs, Ran-Sook Woo, Lin Mei and Michael W. Salter, ErbB4 is a suppressor of long-term potentiation in the adult hippocampus, NeuroReport, 10.1097/WNR.0b013e3282f3da10, 19, 2, (139-143), (2008).
- Victor Z. Chong, Maree J. Webster, Debora A. Rothmond and Cynthia Shannon Weickert, Specific developmental reductions in subventricular zone ErbB1 and ErbB4 mRNA in the human brain, International Journal of Developmental Neuroscience, 10.1016/j.ijdevneu.2008.06.004, 26, 7, (791-803), (2008).
- Sae Shiota, Mamoru Tochigi, Hiroko Shimada, Jun Ohashi, Kiyoto Kasai, Nobumasa Kato, Katsushi Tokunaga and Tsukasa Sasaki, Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population, Journal of Human Genetics, 10.1007/s10038-008-0332-9, 53, 10, (929-935), (2008).
- J D Buxbaum, L Georgieva, J J Young, C Plescia, Y Kajiwara, Y Jiang, V Moskvina, N Norton, T Peirce, H Williams, N J Craddock, L Carroll, G Corfas, K L Davis, M J Owen, S Harroch, T Sakurai and M C O'Donovan, Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene, Molecular Psychiatry, 10.1038/sj.mp.4001991, 13, 2, (162-172), (2007).
- Lin Mei and Wen-Cheng Xiong, Neuregulin 1 in neural development, synaptic plasticity and schizophrenia, Nature Reviews Neuroscience, 10.1038/nrn2392, 9, 6, (437-452), (2008).
- T. Walsh, J. M. McClellan, S. E. McCarthy, A. M. Addington, S. B. Pierce, G. M. Cooper, A. S. Nord, M. Kusenda, D. Malhotra, A. Bhandari, S. M. Stray, C. F. Rippey, P. Roccanova, V. Makarov, B. Lakshmi, R. L. Findling, L. Sikich, T. Stromberg, B. Merriman, N. Gogtay, P. Butler, K. Eckstrand, L. Noory, P. Gochman, R. Long, Z. Chen, S. Davis, C. Baker, E. E. Eichler, P. S. Meltzer, S. F. Nelson, A. B. Singleton, M. K. Lee, J. L. Rapoport, M.-C. King and J. Sebat, Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia, Science, 10.1126/science.1155174, 320, 5875, (539-543), (2008).
- Alexis Kaushansky, Andrew Gordus, Bogdan A. Budnik, William S. Lane, John Rush and Gavin MacBeath, System-wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in Their Recruitment Properties, Chemistry & Biology, 10.1016/j.chembiol.2008.07.006, 15, 8, (808-817), (2008).
- L. Elliot Hong, Ikwunga Wonodi, O. Colin Stine, Braxton D. Mitchell and Gunvant K. Thaker, Evidence of Missense Mutations on the Neuregulin 1 Gene Affecting Function of Prepulse Inhibition, Biological Psychiatry, 10.1016/j.biopsych.2007.05.011, 63, 1, (17-23), (2008).
- Declan N.C. Jones, Jane E. Gartlon, Arpi Minassian, William Perry and Mark A. Geyer, Developing New Drugs for Schizophrenia: From Animals to the Clinic, Animal and Translational Models for CNS Drug Discovery, 10.1016/B978-0-12-373861-5.00008-4, (199-261), (2008).
- Colm M.P. O’Tuathaigh, Daniela Babovic, Gillian O’Meara, Jeremiah J. Clifford, David T. Croke and John L. Waddington, Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2006.04.002, 31, 1, (60-78), (2007).
- Kristin K. Nicodemus, Bhaskar S. Kolachana, Radhakrishna Vakkalanka, Richard E. Straub, Ina Giegling, Michael F. Egan, Dan Rujescu and Daniel R. Weinberger, Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia, Human Genetics, 10.1007/s00439-006-0257-3, 120, 6, (889-906), (2006).
- Zafiris J. Daskalakis, Paul B. Fitzgerald and Bruce K. Christensen, The role of cortical inhibition in the pathophysiology and treatment of schizophrenia, Brain Research Reviews, 10.1016/j.brainresrev.2007.09.006, 56, 2, (427-442), (2007).
- Yuichiro Watanabe, Naoki Fukui, Ayako Nunokawa, Tatsuyuki Muratake, Naoshi Kaneko, Hideaki Kitamura and Toshiyuki Someya, No association between the ERBB3 gene and schizophrenia in a Japanese population, Neuroscience Research, 10.1016/j.neures.2007.01.001, 57, 4, (574-578), (2007).
- Masashi Ikeda, Shinichiro Taya, Kozo Kaibuchi, Nakao Iwata and Norio Ozaki, Molecular Genetic Study of Schizophrenia Based on Neurodevelopmental Hypothesis, Neurogenetics of Psychiatric Disorders, 10.3109/9781420019544.005, (101-116), (2010).
- Bo Li, Ran-Sook Woo, Lin Mei and Roberto Malinow, The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity, Neuron, 10.1016/j.neuron.2007.03.028, 54, 4, (583-597), (2007).
- C.M.P. O’Tuathaigh, D. Babovic, G.J. O’Sullivan, J.J. Clifford, O. Tighe, D.T. Croke, R. Harvey and J.L. Waddington, Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1, Neuroscience, 10.1016/j.neuroscience.2007.03.051, 147, 1, (18-27), (2007).
- John L. Waddington, Aiden P. Corvin, Gary Donohoe, Colm M.P. O'Tuathaigh, Kevin J. Mitchell and Michael Gill, Functional Genomics and Schizophrenia: Endophenotypes and Mutant Models, Psychiatric Clinics of North America, 10.1016/j.psc.2007.04.011, 30, 3, (365-399), (2007).
- Colin A Hodgkinson, David Goldman, Francesca Ducci, Pamela DeRosse, Daniel A Caycedo, Emily R Newman, John M Kane, Alec Roy and Anil K Malhotra, The FEZ1 Gene Shows No Association to Schizophrenia in Caucasian or African American Populations, Neuropsychopharmacology, 10.1038/sj.npp.1301177, 32, 1, (190-196), (2006).
- H. Troy Ghashghaei, Cary Lai and E. S. Anton, Neuronal migration in the adult brain: are we there yet?, Nature Reviews Neuroscience, 10.1038/nrn2074, 8, 2, (141-151), (2007).
- Amanda J. Law, Joel E. Kleinman, Daniel R. Weinberger and Cynthia Shannon Weickert, Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia, Human Molecular Genetics, 10.1093/hmg/ddl449, 16, 2, (129-141), (2006).
- Ricardo Cáceda, Becky Kinkead and Charles B. Nemeroff, Involvement of Neuropeptide Systems in Schizophrenia: Human Studies, Integrating the Neurobiology of Schizophrenia, 10.1016/S0074-7742(06)78011-4, (327-376), (2007).
- R E Straub, B K Lipska, M F Egan, T E Goldberg, J H Callicott, M B Mayhew, R K Vakkalanka, B S Kolachana, J E Kleinman and D R Weinberger, Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression, Molecular Psychiatry, 10.1038/sj.mp.4001988, 12, 9, (854-869), (2007).
- A M Addington, M C Gornick, P Shaw, J Seal, N Gogtay, D Greenstein, L Clasen, M Coffey, P Gochman, R Long and J L Rapoport, Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories, Molecular Psychiatry, 10.1038/sj.mp.4001906, 12, 2, (195-205), (2006).
- Lin Mei and Wen-Cheng Xiong, Neuregulin-1 signaling in schizophrenia, Future Neurology, 10.2217/14796708.2.5.477, 2, 5, (477-480), (2007).
- C Zhao, Z Xu, J Chen, Z Yu, K-L Tong, W-S Lo, F W Pun, S-K Ng, S-Y Tsang and H Xue, Two isoforms of GABAA receptor β2 subunit with different electrophysiological properties: differential expression and genotypical correlations in schizophrenia, Molecular Psychiatry, 10.1038/sj.mp.4001899, 11, 12, (1092-1105), (2006).
- Paul J. Harrison and Amanda J. Law, Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology, Biological Psychiatry, 10.1016/j.biopsych.2005.11.002, 60, 2, (132-140), (2006).
- Richard E. Straub and Daniel R. Weinberger, Schizophrenia Genes - Famine to Feast, Biological Psychiatry, 10.1016/j.biopsych.2006.06.002, 60, 2, (81-83), (2006).
- Fernando S. Goes, Michael Rongione, Yun-Ching Chen, Rachel Karchin, Eran Elhaik, James B. Potash and Katharina Domschke, Exonic DNA Sequencing of ERBB4 in Bipolar Disorder, PLoS ONE, 10.1371/journal.pone.0020242, 6, 5, (e20242), (2011).
- Zeynep Sena Agim, Melda Esendal, Laurent Briollais, Ozgun Uyan, Mehran Meschian, Luis Antonio Mendoza Martinez, Yongmei Ding, A. Nazli Basak, Hilmi Ozcelik and Valerie W. Hu, Discovery, Validation and Characterization of Erbb4 and Nrg1 Haplotypes Using Data from Three Genome-Wide Association Studies of Schizophrenia, PLoS ONE, 10.1371/journal.pone.0053042, 8, 1, (e53042), (2013).
- Undine E. Lang, Imke Puls, Daniel J. Müller, Nathalie Strutz-Seebohm and Jürgen Gallinat, Molecular Mechanisms of Schizophrenia, Cellular Physiology and Biochemistry, 10.1159/000110430, 20, 6, (687-702), (2007).
- James N. Samsom and Albert H. C. Wong, Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models, Frontiers in Psychiatry, 10.3389/fpsyt.2015.00013, 6, (2015).




